(Reuters) -Shares of Indian pharmaceutical companies slid 2% on Wednesday after U.S. President Donald Trump said he intends ...

After steel and aluminium, US President Donald Trump has announced targeted tariffs on automobiles, semiconductors, and ...

Dr. Reddys Laboratories fell 5.8% to Rs 1,128.90, while Zydus Lifesciences dropped 4.8%. Sun Pharma, India's largest ...

Showroom locations have been identified in Mumbai’s BKC business district and Aerocity in New Delhi. Tesla’s initial plans ...

During his second term, President Trump is taking a stronger, more controlled approach, backed by loyalists and targeting ...

US President Donald Trump questioned the allocation of $21 million by USAID to India to boost voter turnout, highlighting ...

Indian stock markets on Wednesday opened lower despite mixed global cues and uncertainties and US tariff concerns announced ...

At the start of trading, the BSE Sensex dropped by 296 points, or 0.39%, to 75,670.80, while the Nifty50 stood at 22,847.25, ...